Morepen Laboratories Limited — Important, 27-12-2024: General Updates

Morepen Laboratories Limited is moving forward by incorporating a new subsidiary, acquiring an 80% equity stake. This new company will focus on the medical devices sector, which presents a significant growth opportunity for Morepen. The new subsidiary will have an authorized and paid-up capital of ₹10,00,000, with equity shares subscribed principally by Morepen for a total investment of ₹8,00,000. This strategic initiative aims to enhance operational capabilities and expand the company’s business footprint. With the majority stake held by Morepen and the remaining 20% by promoters and their affiliates, this move is likely to align with the company’s long-term objectives for diversification and growth within the medical industry. Investors should watch closely as this expansion could bolster future performance and profitability.